Structural analysis of the N-terminal fragment of the antiangiogenic protein endostatin: a molecular dynamics study
- PMID: 21769939
- DOI: 10.1002/prot.23096
Structural analysis of the N-terminal fragment of the antiangiogenic protein endostatin: a molecular dynamics study
Abstract
Endostatin is a potent antiangiogenic protein derived from the noncollagenous domain 1 (NC1) of collagen XVIII. The mechanism by which endostatin exerts its antiangiogenic effect is still incompletely understood. It has been shown that the 27 amino acid N-terminal fragment of murine endostatin has antitumor, antimigration, and antipermeability activities comparable to the full soluble protein. To understand how this peptide can exert such elaborate function, we performed structural analysis using molecular dynamics to evaluate the behavior of this fragment in aqueous environment. Here, we show that the N-terminal peptide of murine endostatin is able to assume a well-defined structure, folding into a zinc-dependent β-hairpin conformation. Analyzing the folding mechanism, we were able to understand why the N-terminal peptide of human endostatin with the same length failed to acquire a stable conformation. Conversely, we were able to predict the successful folding of the R4Q mutant and of a shorter form of the human peptide with 25 residues. Finally, we show that the β-hairpin conformation assumed by the zinc-bound peptide of murine endostatin has a high structural similarity with fragments of another family of angiogenesis inhibitors: the integrin-binding portion of the NC1 domain of collagen IV. Indeed, our docking simulations show that arresten, canstatin, and the endostatin peptide bind to the same spot of αVβ3 integrin, suggesting similar interactions via a common binding site on this receptor.
Copyright © 2011 Wiley-Liss, Inc.
Similar articles
-
Endostatin phenylalanines 31 and 34 define a receptor binding site.Genes Cells. 2005 Sep;10(9):929-39. doi: 10.1111/j.1365-2443.2005.00890.x. Genes Cells. 2005. PMID: 16115201
-
N-terminal fragment of the anti-angiogenic human endostatin binds copper(II) with very high affinity.J Inorg Biochem. 2009 Jul;103(7):940-7. doi: 10.1016/j.jinorgbio.2009.04.006. Epub 2009 Apr 23. J Inorg Biochem. 2009. PMID: 19447499
-
Matrilysin cleavage of corneal collagen type XVIII NC1 domain and generation of a 28-kDa fragment.Invest Ophthalmol Vis Sci. 2001 Oct;42(11):2517-24. Invest Ophthalmol Vis Sci. 2001. PMID: 11581192
-
Research advances of endostatin and its short internal fragments.Curr Protein Pept Sci. 2008 Jun;9(3):275-83. doi: 10.2174/138920308784534050. Curr Protein Pept Sci. 2008. PMID: 18537682 Review.
-
Unraveling the mysteries of endostatin.IUBMB Life. 2009 Jun;61(6):613-26. doi: 10.1002/iub.215. IUBMB Life. 2009. PMID: 19472178 Review.
Cited by
-
Inhibition of Vasculogenic Mimicry and Angiogenesis by an Anti-EGFR IgG1-Human Endostatin-P125A Fusion Protein Reduces Triple Negative Breast Cancer Metastases.Cells. 2021 Oct 27;10(11):2904. doi: 10.3390/cells10112904. Cells. 2021. PMID: 34831127 Free PMC article.
-
Conformation-dependent binding of a Tetrastatin peptide to αvβ3 integrin decreases melanoma progression through FAK/PI3K/Akt pathway inhibition.Sci Rep. 2018 Jun 29;8(1):9837. doi: 10.1038/s41598-018-28003-x. Sci Rep. 2018. PMID: 29959360 Free PMC article.
-
Biological aspects of angiogenesis in multiple myeloma.Int J Hematol. 2011 Dec;94(6):505-18. doi: 10.1007/s12185-011-0963-z. Epub 2011 Nov 17. Int J Hematol. 2011. PMID: 22086206 Review.
-
Hold on or Cut? Integrin- and MMP-Mediated Cell-Matrix Interactions in the Tumor Microenvironment.Int J Mol Sci. 2020 Dec 28;22(1):238. doi: 10.3390/ijms22010238. Int J Mol Sci. 2020. PMID: 33379400 Free PMC article. Review.
-
The extracellular matrix in tumor progression and metastasis.Clin Exp Metastasis. 2019 Jun;36(3):171-198. doi: 10.1007/s10585-019-09966-1. Epub 2019 Apr 11. Clin Exp Metastasis. 2019. PMID: 30972526 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources